Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
出版年份 2013 全文链接
标题
Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
作者
关键词
-
出版物
CELL CYCLE
Volume 13, Issue 2, Pages 199-207
出版商
Informa UK Limited
发表日期
2013-12-06
DOI
10.4161/cc.26953
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling
- (2016) H. Dorota Halicka et al. Aging-US
- Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion
- (2016) Sudha Mannava et al. Aging-US
- Perturbation of nucleotide metabolism - the driving force of oncogene-induced senescence
- (2015) Zbigniew Darzynkiewicz Oncotarget
- Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
- (2015) Hayato Fujita et al. NEOPLASIA
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase
- (2013) Meng Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Depletion of Deoxyribonucleotide Pools Is an Endogenous Source of DNA Damage in Cells Undergoing Oncogene-Induced Senescence
- (2012) Sudha Mannava et al. AMERICAN JOURNAL OF PATHOLOGY
- Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers
- (2012) Xiyong Liu et al. CLINICAL SCIENCE
- Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels
- (2012) Dylan T. Jones et al. PLoS One
- A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study
- (2011) Joseph Chao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
- (2011) B. G. Bitler et al. CANCER RESEARCH
- A Decade of Developmental Cell
- (2011) Daniel H. Wainstock DEVELOPMENTAL CELL
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The essence of senescence
- (2010) T. Kuilman et al. GENES & DEVELOPMENT
- A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
- (2010) Andrea Alimonti et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
- (2010) H. Li et al. MOLECULAR CANCER RESEARCH
- Making the best of PARP inhibitors in ovarian cancer
- (2010) Susana Banerjee et al. Nature Reviews Clinical Oncology
- Genomic analysis of epithelial ovarian cancer
- (2008) John Farley et al. CELL RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- Many roads lead to oncogene-induced senescence
- (2008) S Courtois-Cox et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started